BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31821228)

  • 1. Psychotic Disorders in Patients Who Use Synthetic Cannabinoids.
    Skryabin VY; Vinnikova MA
    J Psychiatr Pract; 2019 Nov; 25(6):485-490. PubMed ID: 31821228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of synthetic cannabinoid-induced psychotic disorders: a single-center analysis of hospitalized patients.
    Skryabin VY; Vinnikova MA
    J Addict Dis; 2018; 37(3-4):135-141. PubMed ID: 31272306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of synthetic cannabinoids in patients with psychotic disorders: case series.
    Celofiga A; Koprivsek J; Klavz J
    J Dual Diagn; 2014; 10(3):168-73. PubMed ID: 25392292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of new classes of recreational drugs-synthetic cannabinoids and cathinones.
    Khullar V; Jain A; Sattari M
    J Gen Intern Med; 2014 Aug; 29(8):1200-4. PubMed ID: 24553958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute intoxication caused by synthetic cannabinoids 5F-ADB and MMB-2201: A case series.
    Barceló B; Pichini S; López-Corominas V; Gomila I; Yates C; Busardò FP; Pellegrini M
    Forensic Sci Int; 2017 Apr; 273():e10-e14. PubMed ID: 28190538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids and psychosis.
    D'Souza DC
    Int Rev Neurobiol; 2007; 78():289-326. PubMed ID: 17349865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosis and synthetic cannabinoids.
    Deng H; Verrico CD; Kosten TR; Nielsen DA
    Psychiatry Res; 2018 Oct; 268():400-412. PubMed ID: 30125871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis.
    Bassir Nia A; Medrano B; Perkel C; Galynker I; Hurd YL
    J Psychopharmacol; 2016 Dec; 30(12):1321-1330. PubMed ID: 27462088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
    Every-Palmer S
    Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical variants of psychoses in patients using synthetic cannabinoids (Spice)].
    Vinnikova MA; Skryabin VY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8):23-26. PubMed ID: 32929920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases.
    Niemi-Pynttäri JA; Sund R; Putkonen H; Vorma H; Wahlbeck K; Pirkola SP
    J Clin Psychiatry; 2013 Jan; 74(1):e94-9. PubMed ID: 23419236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems.
    Fantegrossi WE; Wilson CD; Berquist MD
    Drug Metab Rev; 2018 Feb; 50(1):65-73. PubMed ID: 29385930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential approaches to the treatment of acute psychosis due to the use of synthetic cannabinoids].
    Kekelidze ZI; Klimenko TV; Kozlov AA; Shakhova SM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):21-26. PubMed ID: 29376979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthetic cannabinoid 5F-MDMB-PICA: A case series.
    Kleis J; Germerott T; Halter S; Héroux V; Roehrich J; Schwarz CS; Hess C
    Forensic Sci Int; 2020 Sep; 314():110410. PubMed ID: 32683270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: A case report.
    Durand D; Delgado LL; de la Parra-Pellot DM; Nichols-Vinueza D
    Clin Schizophr Relat Psychoses; 2015 Jan; 8(4):205-8. PubMed ID: 23518784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample.
    Kendler KS; Ohlsson H; Sundquist J; Sundquist K
    Am J Psychiatry; 2019 Sep; 176(9):711-719. PubMed ID: 31055966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
    Besli GE; Ikiz MA; Yildirim S; Saltik S
    J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
    Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
    Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spice intoxication and hyperglycemia].
    Elena-González A; Cuadros-Tito P; Esteban-Gutiérrez G
    An Sist Sanit Navar; 2020 Apr; 43(1):87-91. PubMed ID: 31999272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty psychotic males with Klinefelter's syndrome.
    Sorensen K; Nielsen J
    Acta Psychiatr Scand; 1977 Oct; 56(4):249-55. PubMed ID: 920226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.